Cardiome, Phoenix Pharmahandel sales and marketing update

Cardiome's Correvio GmbH subsidiary granted Phoenix Pharmahandel’s Tamro AB subsidiary rights to distribute IV Brinavess vernakalant in Sweden. The mixed ion channel antagonist is approved in the EU ...